newsfilter
← Latest News
GlobeNewswire·

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results

ZUG, Switzerland and BOSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP) today reported financial results for the second quarter ended June 30, 2026. "The second quarter reflected strong